Commentary by Bani Chander MD, PGY-3. and Ben Bergman MD, PGY-3
Please also see last week’s Class Act Post on the pathogenesis of Rheumatic Heart DiseaseÂ
A 34-year-old Hispanic male presents with the chief complaint …
			
Commentary by Bani Chander MD, PGY-3. and Ben Bergman MD, PGY-3
Please also see last week’s Class Act Post on the pathogenesis of Rheumatic Heart DiseaseÂ
A 34-year-old Hispanic male presents with the chief complaint …
Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. Prior to publication, each commentary is thoroughly reviewed for content by a faculty member.
Commentary by Matt Stein …
Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. These posts focus on evidenced based answers to clinical questions related to patients seen by …
Commentary by Marilena S. Antonopoulos, PharmD, Pharmacology Editor
On July 8th, the FDA notified the manufacturers of fluoroquinolone antimicrobial drugs that a Boxed Warning in the product labeling and a Medication Guide …
Commentary by Howard Leaf, M.D. Assistant Professor, Division of Infectious Diseases and Immunology 
Pressure continues to build for healthcare facilities to act to decrease hospital-acquired infections, particularly those associated with MRSA. This …
Commentary by Rachana Jani MD, PGY-1 and Neal Steigbigel MD, Professor of Medicine (Infectious Diseases/Immunology)
Rachana Jani MD: Â Walking onto an oncology floor, one cannot help but notice the precautionary signs that …
Commentary by Fritz Francois, MD, MS, NYU Division of Gastroenterology
Humans are essentially the only reservoir for Helicobacter pylori, which is estimated to colonize the stomach of about half the world’s …
Commentary by Chirayu Gor, MD
The CDC has issued an alert regarding the outbreak of a rare type of Salmonella, termed Salmonella Saintpaul. Since mid-April, over 140 persons have been identified in …